Kinvestor
News
Markets
Earnings
Insider
Portfolio
Pricing
Get Started
RARE
Ultragenyx Pharmaceutical Inc
Biotechnology
+ Watchlist
View SEC Filings
Overview
Financials
Earnings
Insider
Ownership
Filings
News
Ultragenyx Pharmaceutical Inc (RARE) Earnings
Last reported
April 30, 2026
EPS estimate
-$1.50
EPS actual
—
Revenue est.
$164.2M
Revenue actual
—
Related:
RARE overview
·
RARE financials
·
RARE news